Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix
US11173123B2 · kind B2 · utility
0Cited by
44References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 28, 2018 |
| Grant date | Nov 16, 2021 |
| Priority date | — |
| Expiry date | Nov 28, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical formulation comprising an erosion matrix comprising one or more fumaric acid esters as well as one or more rate-controlling agents, wherein erosion of said erosion matrix permits controlled release of said fumaric acid ester(s).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.